Payment overview · 2025
General Payments
$323.67
12 reported records · 1 companies
Healthcare provider profile · identity verified
Anthony Tam, M.D
Allopathic & Osteopathic Physicians|General Practice · NEW YORK, NY · NPI 1053687491
Verified facts
What the public records show
CMS Open Payments records show Anthony Tam, M.D received $323.67 in general payments during 2025 across 12 reported records.
Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.
Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Vemlidy as an associated drug or biological on 782 records involving 554 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Vemlidy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $323.67 | 100.0% | 12 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $323.67 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. Exact reporting entity; no affiliate inference |
2025 | Vemlidy open payments reported associated product |
CMS Open Payments — General Payments 782 supporting records · 554 recipient NPIs · example record 1234350906 |
Vemlidy · 2024 Exact normalized brand match · 1 Part D row |
93 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1581 | 440 |
| Amlodipine Besylate | Amlodipine Besylate | 1359 | 386 |
| Losartan Potassium | Losartan Potassium | 691 | 201 |
| Metformin Hcl | Metformin Hcl | 669 | 155 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 624 | 207 |
| Omeprazole | Omeprazole | 538 | 191 |
| Metoprolol Succinate | Metoprolol Succinate | 441 | 130 |
| Tamsulosin Hcl | Tamsulosin Hcl | 384 | 114 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 352 | 197 |
| Alendronate Sodium | Alendronate Sodium | 331 | 100 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 321 | 86 |
| Raloxifene Hcl | Raloxifene Hcl | 263 | 81 |
| Januvia | Sitagliptin Phosphate | 247 | 56 |
| Simvastatin | Simvastatin | 215 | 64 |
| Jardiance | Empagliflozin | 213 | 55 |
| Diclofenac Sodium | Diclofenac Sodium | 209 | 108 |
| Finasteride | Finasteride | 198 | 61 |
| Meclizine Hcl | Meclizine Hcl | 193 | 128 |
| Ammonium Lactate | Ammonium Lactate | 191 | 102 |
| Donepezil Hcl | Donepezil Hcl | 191 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 190 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 188 | 58 |
| Diclofenac Epolamine | Diclofenac Epolamine | 186 | 82 |
| Fluticasone Propionate | Fluticasone Propionate | 183 | 76 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 176 | 49 |
| Irbesartan | Irbesartan | 169 | 50 |
| Azelastine Hcl | Azelastine Hcl | 161 | 78 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 157 | 63 |
| Farxiga | Dapagliflozin Propanediol | 153 | 36 |
| Celecoxib | Celecoxib | 151 | 84 |
| Glipizide Er | Glipizide | 151 | 40 |
| Naproxen | Naproxen | 151 | 117 |
| Azithromycin | Azithromycin | 149 | 121 |
| Montelukast Sodium | Montelukast Sodium | 137 | 48 |
| Citalopram Hbr | Citalopram Hydrobromide | 121 | 32 |
| Atenolol | Atenolol | 115 | 31 |
| Famotidine | Famotidine | 112 | 43 |
| Allopurinol | Allopurinol | 109 | 29 |
| Lisinopril | Lisinopril | 103 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 103 | 34 |
| Tradjenta | Linagliptin | 99 | 22 |
| Nifedipine Er | Nifedipine | 97 | 31 |
| Glimepiride | Glimepiride | 94 | 20 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 93 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 93 | 31 |
| Vemlidy | Tenofovir Alafenamide | 93 | 15 |
| Rybelsus | Semaglutide | 90 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 88 | 21 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 84 | 22 |
| Telmisartan | Telmisartan | 83 | 25 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 81 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 26 |
| Mometasone Furoate | Mometasone Furoate | 76 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 75 | 25 |
| Clobetasol Propionate | Clobetasol Propionate | 74 | 42 |
| Dexlansoprazole Dr | Dexlansoprazole | 74 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 74 | 30 |
| Hydrocortisone | Hydrocortisone | 73 | 33 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 71 | 21 |
| Nebivolol Hcl | Nebivolol Hcl | 71 | 17 |
| Nexium | Esomeprazole Magnesium | 67 | 13 |
| Xarelto | Rivaroxaban | 62 | 14 |
| Acarbose | Acarbose | 59 | 11 |
| Loperamide | Loperamide Hcl | 55 | 50 |
| Procto-Med Hc | Hydrocortisone | 55 | 20 |
| Eliquis | Apixaban | 53 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 53 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 52 | 26 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 52 | suppressed |
| Ozempic | Semaglutide | 50 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 48 | 12 |
| Gabapentin | Gabapentin | 48 | 22 |
| Folic Acid | Folic Acid | 45 | 16 |
| Meloxicam | Meloxicam | 45 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 43 | 14 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 43 | 25 |
| Clotrimazole | Clotrimazole | 42 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 41 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 40 | 31 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 39 | suppressed |
| Carvedilol | Carvedilol | 38 | 16 |
| Lidocaine | Lidocaine | 38 | 19 |
| Mupirocin | Mupirocin | 38 | 28 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 38 | 12 |
| Amoxicillin | Amoxicillin | 37 | 28 |
| Mirtazapine | Mirtazapine | 37 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 36 | 14 |
| Vascepa | Icosapent Ethyl | 36 | 17 |
| Alcohol Pads | Alcohol Antiseptic Pads | 35 | 16 |
| Ezetimibe | Ezetimibe | 35 | 14 |
| Ketoconazole | Ketoconazole | 35 | 11 |
| Potassium Chloride | Potassium Chloride | 35 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 34 | suppressed |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 33 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 32 | 13 |
| Sucralfate | Sucralfate | 32 | suppressed |
| Dutasteride | Dutasteride | 31 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 26 |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 31 | 14 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 29 | suppressed |
| Entecavir | Entecavir | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Ciclopirox | Ciclopirox | 28 | 13 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 27 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Colchicine | Colchicine | 25 | 13 |
| Fenofibrate | Fenofibrate,micronized | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | 17 |
| Jentadueto | Linagliptin/Metformin Hcl | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 24 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 20 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 20 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 14 |
| Furosemide | Furosemide | 19 | 11 |
| Methimazole | Methimazole | 19 | suppressed |
| Nystatin | Nystatin | 19 | 11 |
| Proctozone-Hc | Hydrocortisone | 19 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 18 | suppressed |
| Fluocinolone Acetonide Oil | Fluocinolone Acetonide Oil | 18 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 18 | 11 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Prolia | Denosumab | 16 | 15 |
| Valsartan | Valsartan | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 14 |
| Edarbi | Azilsartan Medoxomil | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Dexilant | Dexlansoprazole | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Spironolactone | Spironolactone | 14 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Livalo | Pitavastatin Calcium | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Silodosin | Silodosin | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Fluocinonide | Fluocinonide | 12 | suppressed |
| Prednisone | Prednisone | 12 | 11 |
| Repaglinide | Repaglinide | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $323.67 · 12 records | Gilead Sciences, Inc. | — | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Gilead Sciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error